A soldier wounded in Korea in 1951 had better survival odds than soldiers wounded in World War II despite heavier casualties and harsher conditions. The difference was time. Mobile Army Surgical ...

Panelists discuss how GLP-1 therapies show dual metabolic and hepatic benefits, redefining MASH management. Panelists discuss how GLP-1 receptor agonists, originally developed for diabetes and obesity ...

Potatoes are a kitchen hero, turning up in all kinds of dishes—but when it comes to mashed potatoes, they truly shine. The key to perfect mashed potatoes lies in how you prepare and cook them, and one ...

Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression. Panelists discuss how proactive screening and diagnostic strategies can identify ...

Julia Child was a longtime Food & Wine contributor, a household name, and a champion of French cuisine. She authored Mastering the Art of French Cooking, a world-renowned tome with more than 500 ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...